RxDoctor Payments Data

Leonard Gehl

Cardiovascular Disease · Pittsburgh, PANPI 1245299718

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.5% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for cardiovascular disease clinicians in PA, where the typical reported total is $1,447.

$1,514in general payments, 2019–2025

Across 87 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$297
  • Boston Scientific$220
  • Actelion Pharmaceuticals US, Inc.$180
  • Pfizer$116
  • Astellas Pharma US Inc$98
  • Biotronik Inc.$92
  • plus $511 from 13 others

What the payments were for

  • Food & beverage$1,38692%
  • Education$1288%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,514 in reported general payments places this provider in the 50th percentile of 1,250 cardiovascular disease providers in Pennsylvania.

See all cardiovascular disease providers in Pennsylvania →

Other cardiovascular disease in Pittsburgh

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →